The prospective capital injection would be structured as preferred equity, sources said, with final terms yet to be agreed. The deal, if concluded, would allow BDT & MSD Partners— which previously led a $3 billion senior preferred stock investment in Acrisure in 2021— to partially redeem its existing position in the company.
Private equity giant Bain Capital in talks for giant Acrisure deal
Leave a Reply